Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
News|Articles|February 2, 2017
- Pharmaceutical Technology-02-02-2017
- Volume 41
- Issue 2
Pharmaceutical Analyzer Uses Focus Tracking Technology
The RA802 Pharmaceutical Analyzer from Renishaw is a compact benchtop Raman imaging system that enables users to formulate tablets by speeding up the analysis of tablet composition and structure.
The RA802 Pharmaceutical Analyzer from Renishaw is a compact benchtop Raman imaging system that enables users to formulate tablets by speeding up the analysis of tablet composition and structure. The analyzer brings together the chemical analysis power of Raman spectroscopy and advanced imaging technologies. Users can reveal detailed chemical and physical information about the contents of their sample, from the distribution and size of API domains to the physical topography.
The system uses Renishaw’s LiveTrack focus-tracking technology to enable users to analyze samples with uneven, curved, or rough surfaces without requiring any sample preparation. Intact tablets can be analyzed, or they can be split or sliced to reveal their internal structures. LiveTrack continuously adjusts the sample’s height, producing three-dimensional chemical maps of a tablet’s surface.
Articles in this issue
almost 10 years ago
A Risk-Based Approach to Stainless Steel Equipment Maintenancealmost 10 years ago
Pumping Fluids in Biopharmaceutical Processingalmost 10 years ago
Moving Forward with Adaptive Licensingalmost 10 years ago
Collaboration Key to Meeting Excipient GMP Requirementsalmost 10 years ago
Regulatory Reform Is Not That Simplealmost 10 years ago
Mass Spec Sheds New Light on Biologics Drug Developmentalmost 10 years ago
Evaluating E&L Studies for Single-Use Systemsalmost 10 years ago
Ensuring Sterility in Small-Scale Productionalmost 10 years ago
Viewpoint: Challenges and Opportunities for CDMOsRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
5